Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders

/by

Authors: María Fernández-Trapero, Carmen Pérez-Díaz, Francisco Espejo-Porras, Eva de Lago, Javier Fernández-Ruiz Published in Biomolecules February 2020 Abstract The phytocannabinoid-based medicine Sativex® is currently marketed for the treatment of spasticity and…

Read more

Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms

/by

Authors: Marieka V. DeVuono, Linda A. Parker Published in Mary Ann Liebert, Inc Publishers June 2020 Abstract Introduction Cannabinoids have long been known for their ability to treat nausea and vomiting….

Read more

Cannabidiol for Viral Diseases: Hype or Hope?

/by

Authors: Alex Mabou Tagne, Barbara Pacchetti, Mikael Sodergren, Marco Cosentino, and Franca Marino Published in Mary Ann Liebert, Inc Publishers June 2020 Abstract Background: The possibility of cannabidiol (CBD) to be…

Read more

Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study

/by

Authors: Joshua Aviram, Yelena Vysotski, Paula Berman, Gil M Lewitus, Elon Eisenberg, David Meiri Published in MDPI June 2020 Background Medical cannabis (MC) treatment for migraine is practically emerging, although…

Read more

Acute and residual mood and cognitive performance of young adults following smoked cannabis

/by

Authors: Justin Matheson, Robert E. Mann, Beth Sproule, Marilyn A. Huestis, Christine M. Wickens, Gina Stoduto, Tony P. George, Jürgen Rehm, Bernard Le Foll, Bruna Brands Published in Science Direct…

Read more

Emerging evidence for Cannabis Role in Opioid Use Disorder

/by

Authors: Beth Weise and Adrianne R. Wilson-Poe Published in Mary Ann Leibert Inc. Publishers September 2018 Abstract Introduction: The opioid epidemic has become an immense problem in North America, and…

Read more

Cannabis Systematics at the Levels of Family, Genus and Species

/by

Authors: John N. McPartland Published in Mary Ann Leibert Inc. Publishers October 2018   Abstract New concepts are reviewed in Cannabis systematics, including phylogenetics and nomenclature. The family Cannabaceaenow includes…

Read more

Effects on Cannabidiol on Emotion in Psychosis Risk: An FMRI Investigation

/by

Authors: Cathay Davies, Robin Wilson, Elizabeth Appiah-Kusi, Michael Brammer, Jesus Perez, Robin Murray, Paul Allen, Matthijas Bossong, Philip McGuire and Sagnik Bhattacharyya Published in Schizophrenia Bulletin May 2020   Abstract…

Read more

First Aid for Protestors- A Good Samaritan’s Guide & Packing List

/by

Are you attending protests in support of dismantling White Supremacy? Dr. Sarah Mann gives tips to help you care for yourself and those around you.

Read more

The effect of concomitant cannabinoids during immune checkpoint inhibitor treatment of advanced stage malignancy.

/by

Authors: Adam Biedny, Susan Szpunar, Ahmed Abdalla, Zyad Kafri, Tarik H. Hadid Published in Journal of Clinical Oncology May 2020   Abstract Background: Immune checkpoint inhibitors are used in treatment…

Read more

Efficacy of cannabidiol treatment in experimental MS is due to immunosuppressive activity of myeloid cells in CNS downregulating recruitment of CD4+ T cells, proinflammatory chemokines and gasdermin D expression

/by

Authors: Nicholas Dopkins, Kiesha Wilson, Kathryn Miranda, Prakash S Nagarkatti and Mitzi Nagarkatti Published in The Journal of Immunology May 2020   Abstract Cannabidiol (CBD) is a nonpsychoactive ingredient from…

Read more

Cannabidiol for psychosis: A review of 4 studies

/by

Authors: Sy Atezaz Saeed, MD, MS, and Kathryn E. Clary, BA Published in Current Psychiatry June 2020   Introduction There has been increasing interest in the medicinal use of cannabidiol…

Read more